Page last updated: 2024-08-23

nigericin and B-Cell Chronic Lymphocytic Leukemia

nigericin has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, DA; Castro, JE; Choi, MY; Kipps, TJ; Lu, D; Yu, J1

Other Studies

1 other study(ies) available for nigericin and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Aug-09, Volume: 108, Issue:32

    Topics: Apoptosis; beta Catenin; Calcium; Down-Regulation; Gene Expression Regulation, Leukemic; Genes, Neoplasm; HEK293 Cells; Humans; LDL-Receptor Related Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Low Density Lipoprotein Receptor-Related Protein-6; Nigericin; Phosphorylation; Pyrans; Signal Transduction; Thapsigargin; Wnt Proteins

2011